Nine Chapters Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-28,900
| Closed | -$1.05M | – | 297 |
|
|
2016
Q4 | $1.05M | Buy |
28,900
+23,200
| +407% | +$841K | 1.77% | 10 |
|
|
2016
Q3 | $262K | Buy |
+5,700
| New | +$262K | 1.85% | 17 |
|
|
2015
Q4 | – | Sell |
-141,600
| Closed | -$8M | – | 495 |
|
|
2015
Q3 | $8M | Buy |
141,600
+96,600
| +215% | +$5.45M | 0.7% | 10 |
|
|
2015
Q2 | $2.66M | Sell |
45,000
-8,500
| -16% | -$502K | 0.22% | 116 |
|
|
2015
Q1 | $3.33M | Buy |
53,500
+18,400
| +52% | +$1.15M | 0.28% | 76 |
|
|
2014
Q4 | $2.02M | Sell |
35,100
-58,000
| -62% | -$3.34M | 0.17% | 154 |
|
|
2014
Q3 | $5M | Sell |
93,100
-27,800
| -23% | -$1.49M | 0.45% | 41 |
|
|
2014
Q2 | $6.34M | Buy |
120,900
+116,300
| +2,528% | +$6.1M | 0.52% | 29 |
|
|
2014
Q1 | $243K | Buy |
+4,600
| New | +$243K | 0.03% | 673 |
|
|
2013
Q3 | – | Sell |
-18,600
| Closed | -$729K | – | 906 |
|
|
2013
Q2 | $729K | Buy |
+18,600
| New | +$729K | 0.13% | 248 |
|